Abstract: The measuring device with electric voltage divider comprises a first measuring resistor connected between a voltage measurement input and a common point, and a second measuring resistor connected between said common point and a reference electric ground. A measurement output is connected to the common point. An outer shielding enclosure surrounds the first and second measuring resistors and is connected to the reference electric ground. An inner capacitive electrode surrounding the first and second measuring resistors is arranged inside said outer shielding enclosure. To improve the phase difference and passband, the device comprises a phase difference compensation circuit connected between said inner capacitive electrode and said common point.

Abstract: The measuring device with electric voltage divider comprises a first measuring resistor connected between a voltage measurement input and a common point, and a second measuring resistor connected between said common point and a reference electric ground. A measurement output is connected to the common point. An outer shielding enclosure surrounds the first and second measuring resistors and is connected to the reference electric ground. An inner capacitive electrode surrounding the first and second measuring resistors is arranged inside said outer shielding enclosure. To improve the phase difference and passband, the device comprises a phase difference compensation circuit connected between said inner capacitive electrode and said common point.

Abstract: The invention relates to a transport system, comprising a transport track (9), made of at least one rail, at least one vehicle to be transported and a rolling device, whereby said vehicle, provided with the rolling device, has a rolling resistance on said rail, said transport track comprises several descending sections (14?, 14?, 14??), having a descending gradient which is sufficient to increase the rolling resistance and insufficient to generate a continuous acceleration of the vehicle on the rail and ascending sections (12?, 12?, 12??) and whereby the transport track has a course, along which no vehicle at a point is lifted higher than the altitude of said vehicle at this point on a transport track with a single descending section, having the aforementioned gradient.

Abstract: The invention relates to a transport system, comprising a transport track (9), made of at least one rail, at least one vehicle to be transported and a rolling device, whereby said vehicle, provided with the rolling device, has a rolling resistance on said rail, said transport track comprises several descending sections (14?, 14?, 14??), having a descending gradient which is sufficient to increase the rolling resistance and insufficient to generate a continuous acceleration of the vehicle on the rail and ascending sections (12?, 12?, 12??) and whereby the transport track has a course, along which no vehicle at a point is lifted higher than the altitude of said vehicle at this point on a transport track with a single descending section, having the aforementioned gradient.

Abstract: The present invention relates to an improvement in the clearances 12 between a casing and the moving blades 11 of a rotor 1 of a turbomachine, in particular a casing provided for this purpose, and also to a turbomachine fitted with such a casing. The invention applies in particular to aircraft turbojet engines. It relates more particularly to a turbomachine inner casing 21 comprising a plurality of annular shrouds 23 that are provided with flanges 24 for joining two adjacent shrouds 23 together. According to the invention, this inner casing 21 further includes: at least one circumferential heat shield 5 covering the flanges 24 in contact with two adjacent shrouds 23; and a cavity 6 filled with a first thermal insulation 8, said cavity being located between a concave internal surface 51a, 52a of the heat shield 5 and the flanges 24. The heat shield 5 is formed by a plurality of sectors 50 joined end to end.

Abstract: The invention relates to a device for ventilating a high pressure turbine rotor which comprises a turbine disk and an upstream end plate. A first circuit for cooling blades delivers a first air flow via main injectors and holes formed in the end plate. A second cooling circuit delivers a second air flow through a discharge baffle situated downstream from the compressor, a fraction of this second flow serving to cool the upstream top face of the end plate through a second baffle situated beneath the main injectors. A branch connection is provided between the first circuit and the enclosure situated downstream from the second baffle and it delivers a third flow which is set into pre-rotation by additional injector means formed in the form of inclined bores.

Abstract: The invention relates to a device for ventilating a high pressure turbine rotor which comprises a turbine disk and an upstream end plate. A first circuit for cooling blades delivers a first air flow via main injectors and holes formed in the end plate. A second cooling circuit delivers a second air flow through a discharge baffle situated downstream from the compressor, a fraction of this second flow serving to cool the upstream top face of the end plate through a second baffle situated beneath the main injectors. A branch connection is provided between the first circuit and the enclosure situated downstream from the second baffle and it delivers a third flow which is set into pre-rotation by additional injector means formed in the form of inclined bores.

Abstract: A compound selected from those of formula (I): ##STR1## where m is equal to 0 or 1 and Het, A, X, R,R.sub.1, R.sub.2, R.sub.3, R.sub.4 and the ring ##STR2## are defined in the description, and a medicinal product comprising the same for treating an inflammatory disorder.

Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## wherein R.sub.1, W and Y are as defined in the description, its geometric and/or optical isomers, and its pharmaceutically-acceptable addition salts with an acid or a base useful as analgesies.

Abstract: A compound selected from those of formula (I): ##STR1## where m is equal to 0 or 1andHet, A, X, R, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and the ring ##STR2## are defined in the description, and a medicinal product comprising the same for treating an inflammatory disorder.

Abstract: A compound which is selected from those of formula (I) : ##STR1## in which A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the description,its optical isomers,and its addition salts thereof with a pharmaceutically-acceptable acid or base,and medicinal products containing the same which are useful for treating a disorder of the melatoninergic system.

Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the description, the optical isomers thereof, and the addition salts thereof with a pharmaceutically acceptable acid or baseand medicinal product containing the same, useful for treating a mammal afflicted with a pathology associated with the sigma receptors.

Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the description, the optical isomers thereof, and the addition salts thereof with a pharmaceutically acceptable acid or base and medicinal product containing the same, useful for treating a mammal afflicted with a pathology associated with the sigma receptors.

Abstract: A compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description.

Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined herein for use in the treatment of a disorder of the melatoninergic system.

Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the description, the optical isomers thereof, and the addition salts thereof with a pharmaceutically acceptable acid or base and medicinal product containing the same, useful for treating a mammal afflicted with a pathology associated with the sigma receptors.

Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## wherein Ar, n, B and A are as defined in the description, to their optical isomers, and to their addition salts there of with a pharmaceutically-acceptable acid or base. The compounds are useful for treating or preventing anxiety and depression.

Abstract: The invention relates to compounds of the general formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and Z are as defined in the description, their optical isomers and their addition salts with a pharmaceutically-acceptable acid or base and medicaments containing the same, useful in the treatment and prevention of stress, anxiety, and related ailments.

Abstract: The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and medicinal product containing the same in order to treat a mammal afflicted with a peroxydation phenomenom.

Abstract: Compounds of the general formula: ##STR1## wherein m, X, Y, A, R.sub.2 and R.sub.3 are defined in the description.